LORI LAMAN: Open Payments
NPI 1295906378 · ALAMO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 37 payments from 10 companies in 2025. Trend: 2023 $656 · 2024 $524 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| ABBVIE INC. | 9 | $166 |
| PFIZER INC. | 5 | $87 |
| Novo Nordisk Inc | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Lundbeck LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Ardelyx, Inc. | 1 | $16 |
Products named: REXULTI, QULIPTA, VRAYLAR, ELIQUIS, AIRSUPRA, MOUNJARO, NURTEC ODT, UBRELVY.
Industry payments across TN — which companies pay providers there.
